chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: F
Vaccine: FLUX, HEP, HEPA, FLUX, FLUX
Symptoms: Pain
Clinical narrative: Case number PHHY2016US085029, is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (VAERS reference number: 630361) website on 20 Jun 2016. This report refers to a 40 year old female patient. Past historical condition included irritable bowel syndrome and prior vaccine history of influenza (refer case: PHHY2016US085113) and patient experienced sore and Hepatitis A and Hepatitis B. Current conditions included allergies, mental illness. No concomitant medication was not reported. The patient was vaccinated with seasonal influenza vaccine (manufacturer: unknown, batch number: not reported) on 28 Jan 2016 into arm. On the same day after vaccination the patient developed soreness at site of injection and surrounding area for some days no treatment. The outcome of event was reported as completely recovered. The seriousness of event was reported as non serious. The causality of event was not reported.
Sex: F
Vaccine: FLUX, HEP, HEPA, FLUX, FLUX
Symptoms: Injection site pain
Clinical narrative: Case number PHHY2016US085113, is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (VAERS reference number: 630361) website on 20 Jun 2016. This report refers to a 40 year old female patient. Medical history and concomitant medication were not reported. The patient was vaccinated with seasonal influenza vaccine (manufacturer: unknown, batch number: not reported). On an unspecified date, the patient experienced sore (unspecified). The outcome, seriousness and causality was unknown.
Sex: F
Vaccine: FLUX, HEP, HEPA, FLUX, FLUX
Symptoms: Hepatitis A, Hepatitis B, Injection site pain
Clinical narrative: Case number PHHY2016US085113, is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (VAERS reference number: 630361) website on 20 Jun 2016. This report refers to a 40 year old female patient. Medical history and concomitant medication were not reported. The patient was vaccinated with seasonal influenza vaccine (manufacturer: unknown, batch number: not reported). On an unspecified date, the patient experienced sore (unspecified). The outcome, seriousness and causality was unknown.
Sex: F
Vaccine: FLUX, HEP, HEPA, FLUX, FLUX
Symptoms: Pain
Clinical narrative: Case number PHHY2016US085113, is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (VAERS reference number: 630361) website on 20 Jun 2016. This report refers to a 40 year old female patient. Medical history and concomitant medication were not reported. The patient was vaccinated with seasonal influenza vaccine (manufacturer: unknown, batch number: not reported). On an unspecified date, the patient experienced sore (unspecified). The outcome, seriousness and causality was unknown.
Age: 66.0
Sex: M
Vaccine: FLUX, PNC13, FLUX, PNC13
Symptoms: Chills, Cough, Dyspnoea, Fatigue, Paranasal sinus hypersecretion
Clinical narrative: Case number PHHY2016US084747, is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (VAERS reference number: 630747) website on 20 Jun 2016. This report refers to a 66-year-old male patient. Past medical history was not reported. Current condition included high blood pressure. Concomitant medications were not reported. The patient was vaccinated with seasonal influenza vaccine (manufacturer unknown, batch number: not reported) with first dose of PREVNAR 13 (other manufacturer, batch number: not reported) both on 15 Oct 2015. On 16 Oct 2015, the patient experienced fever, chills, cough, labored breathing, wheezing, sinus (reported as running), hives skin problems (reported as prolonged) and fatigue (reported as weeks and weeks). The patient visited the emergency room. The outcome of the events were reported as complete recovery on an unknown date. The seriousness of the events was reported as non serious. The causality of the events was not reported. Seriousness assessment of the event urticaria, dyspnea and wheezing was upgraded based on information available in the source document.
Age: 66.0
Sex: M
Vaccine: FLUX, PNC13, FLUX, PNC13
Symptoms: Pyrexia, Skin disorder, Urticaria, Wheezing
Clinical narrative: Case number PHHY2016US084747, is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (VAERS reference number: 630747) website on 20 Jun 2016. This report refers to a 66-year-old male patient. Past medical history was not reported. Current condition included high blood pressure. Concomitant medications were not reported. The patient was vaccinated with seasonal influenza vaccine (manufacturer unknown, batch number: not reported) with first dose of PREVNAR 13 (other manufacturer, batch number: not reported) both on 15 Oct 2015. On 16 Oct 2015, the patient experienced fever, chills, cough, labored breathing, wheezing, sinus (reported as running), hives skin problems (reported as prolonged) and fatigue (reported as weeks and weeks). The patient visited the emergency room. The outcome of the events were reported as complete recovery on an unknown date. The seriousness of the events was reported as non serious. The causality of the events was not reported. Seriousness assessment of the event urticaria, dyspnea and wheezing was upgraded based on information available in the source document.
Sex: F
Vaccine: TDAP, FLUX
Symptoms: Chest discomfort, Impaired work ability, Injection site erythema, Injection site swelling, Injection site warmth
Clinical narrative: Case number PHHY2016US090001 is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (VAERS reference number: 630951) website on 20 Jun 2016. This report refers to a 43 year old female patient. Historical condition included obesity. Current condition included ADACEL. The patient was vaccinated with Unknown Influenza Virus Vaccine Inn (manufacturer unknown, batch number: not reported) on an unknown date. On an unknown date, the patient got fever 102 (normal range and unit not reported) which was with annual flu vaccines (unspecified) and took ADVIL or TYLENOL for this. The patient took a few days off work. The outcome of the event was unknown. The event was unknown. The event were reported as non serious by the health care professional. The causality of the event was not reported.
Sex: F
Vaccine: TDAP, FLUX
Symptoms: Local reaction, Pyrexia, Vaccination complication
Clinical narrative: Case number PHHY2016US090001 is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (VAERS reference number: 630951) website on 20 Jun 2016. This report refers to a 43 year old female patient. Historical condition included obesity. Current condition included ADACEL. The patient was vaccinated with Unknown Influenza Virus Vaccine Inn (manufacturer unknown, batch number: not reported) on an unknown date. On an unknown date, the patient got fever 102 (normal range and unit not reported) which was with annual flu vaccines (unspecified) and took ADVIL or TYLENOL for this. The patient took a few days off work. The outcome of the event was unknown. The event was unknown. The event were reported as non serious by the health care professional. The causality of the event was not reported.
Sex: F
Vaccine: TDAP, FLUX
Symptoms: Pyrexia
Clinical narrative: Case number PHHY2016US090001 is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (VAERS reference number: 630951) website on 20 Jun 2016. This report refers to a 43 year old female patient. Historical condition included obesity. Current condition included ADACEL. The patient was vaccinated with Unknown Influenza Virus Vaccine Inn (manufacturer unknown, batch number: not reported) on an unknown date. On an unknown date, the patient got fever 102 (normal range and unit not reported) which was with annual flu vaccines (unspecified) and took ADVIL or TYLENOL for this. The patient took a few days off work. The outcome of the event was unknown. The event was unknown. The event were reported as non serious by the health care professional. The causality of the event was not reported.
Sex: F
Vaccine: VARZOS, FLUX
Symptoms: Injection site pain, Injection site pruritus, Injection site reaction, Injection site swelling
Clinical narrative: Case number PHHY2016US106827, is an initial spontaneous report received Vaccine Adverse Event Reporting System (VAERS reference number: 631163) website on 01 Aug 2016. This report refers to an unknown age of female patient. Past medical history and concomitant medication were not reported. The patient was vaccinated with influenza vaccine (unknown whether seasonal or pandemic, manufacturer and batch number: not reported) on an unknown date. On an unspecified date, the patient suffered with drug reaction as allergy to vaccine and chronic pain. The outcome, seriousness and causality of events were not reported.
Sex: F
Vaccine: VARZOS, FLUX
Symptoms: Allergy to vaccine, Pain
Clinical narrative: Case number PHHY2016US106827, is an initial spontaneous report received Vaccine Adverse Event Reporting System (VAERS reference number: 631163) website on 01 Aug 2016. This report refers to an unknown age of female patient. Past medical history and concomitant medication were not reported. The patient was vaccinated with influenza vaccine (unknown whether seasonal or pandemic, manufacturer and batch number: not reported) on an unknown date. On an unspecified date, the patient suffered with drug reaction as allergy to vaccine and chronic pain. The outcome, seriousness and causality of events were not reported.
Sex: U
Vaccine: FLUX, TDAP, FLUX, TDAP
Symptoms: Pleural effusion
Clinical narrative: Case number PHHY2016US088035, is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (VAERS reference number: 631777) website on 20 Jun 2016. This report refers to a patient of an unknown age and gender. Past medical history, current condition and concomitant medications were not reported. The patient was vaccinated with Influenza virus vaccine (Manufacturer unknown, batch number: not reported) and Diphtheria Tetanus Pertussis vaccine (Manufacturer unknown, batch number: not reported) on an unknown date. After vaccination, the patient experienced pleural effusion. Laboratory tests and corrective treatments were not reported. Follow-up information received from physician on 19 October 2015. It was reported that no additional clinical data was available. Outcome of the events was reported as unknown. Seriousness of the events was reported as non serious and causality of the events was not reported.
Sex: U
Vaccine: FLUX, FLUX
Symptoms: Lymphopenia
Clinical narrative: Case number PHHY2016US087942, is an initial spontaneous report received Vaccine Adverse Event Reporting System (VAERS reference number: 631778) website on 20 Jun 2016. This report refers to a patient of an unknown age and gender. Past medical history and concomitant medication were not reported. The patient was vaccinated with seasonal influenza vaccine (manufacturer and batch number: not reported) on an unknown date. Following the vaccination, the patient experienced lymphocytopenia. The outcome of the event was reported as unknown. The seriousness of the event was reported as non serious. The causality of the event was not reported.
Sex: M
Vaccine: FLUX, PNC13, TDAP, FLUX, PNC13, TDAP
Symptoms: Pyrexia
Clinical narrative: Case number PHHY2016US088600 is an initial spontaneous report received from Nurse via Vaccine Adverse Event Reporting System (VAERS reference number: 631985) on 20 Jun 2016. This report refers to a male patient of an unknown age. Past medical history included heart transplant. The patient was a heart transplant recipient. Concomitant medication was not reported. The patient was vaccinated with Seasonal Influenza vaccine, (manufacturer unknown, batch number: not reported), TDAP vaccine (manufacturer: unknown, batch number: not reported) and PREVNAR 13 (other manufacturer, batch number: not reported) on an unknown date. Following the vaccination, the patient experienced a fever of 104 degree Fahrenheit and patient was taken to an emergency room. Laboratory data and corrective treatments were not reported. The outcome, seriousness and causality were not reported. Seriousness of the event was upgraded to serious (medically significant) based on available information on the source document.
Sex: F
Vaccine: FLUX, FLUX
Symptoms: Hypersensitivity, Vaccination complication
Clinical narrative: Case number PHHY2016US087946 is an initial spontaneous report received from a health professional via other company (Pfizer, Manufacturer Report Number: 2016180314) via the Vaccine Adverse Event Reporting System (VAERS reference number: 631991) website on 20 Jun 2016. This report refers to a female patient of an unknown age. Medical history and concomitant medication was not reported. The patient was vaccinated with Seasonal Influenza Virus Vaccine (manufacturer and batch number: unknown) on an unknown date. The patient developed allergy due to flu vaccine. The outcome of the event was reported as unknown. Seriousness of the event was reported as non serious and causality was not reported. Seriousness of the events hypersensitivity was upgraded based on the information available in the source documents.
Age: 57.0
Sex: F
Vaccine: FLU(H1N1), FLUX
Symptoms: Disturbance in attention, Dizziness, Gait disturbance
Clinical narrative: Case number PHHY2016US088800, is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (VAERS reference number: 632026) website on 20 Jun 2016. This report refers to a 57 year old female patient. Historical condition was not reported. Current condition included multiple sclerosis (MS). It was also reported that, no other vaccines (unspecified name) had affected the patient in any way. Concomitant medications included vitamins (unspecified), joint medications (unspecified) and the patient's basic medications (unspecified). The patient was vaccinated with Seasonal Influenza Virus Vaccine Inn (manufacturer unknown, batch number: not reported) on 19 Apr 2016. On the same day of vaccination, the patient had extreme dizziness and she was hard to focus or walk. The reporter knew that dizziness was mentioned in the handout, but this was rough. The outcome of the events was not reported. The events were considered non serious by the health care professional. The causality of the events was not reported.
Sex: U
Vaccine: FLUX, VARZOS, FLUX, VARZOS
Symptoms: Blepharospasm
Clinical narrative: Case number PHHY2016US088110, is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (VAERS reference number 632698) website on 20 Jun 2016. This report refers to a patient of an unknown age and gender. Past medical history, current condition and concomitant medications were not reported. The patient was vaccinated with Influenza virus vaccine seasonal (manufacturer unknown, batch number: not reported) and ZOSTAVAX (other manufacturer, batch number: not reported) in Apr 2012 (reported as 4 years ago). After vaccination, the patient experienced a twitch in her eye. Outcome of the event was reported as unknown. Seriousness of the event was reported as non serious and causality of the event was not reported.
Age: 71.0
Sex: F
Vaccine: FLUX, FLUX
Symptoms: Erythema, Immediate post-injection reaction, Pain, Swelling
Clinical narrative: Case number PHHY2016US088931, is an initial spontaneous report received from a consumer via phone via a pharmaceutical company (Pfizer) (Pfizer reference number: 2016164800) through the Vaccine Adverse Event Reporting System (VAERS reference number: 632868) web site on 20 Jun 2016. This report refers to a 71 year old female patient. Historical condition included fibromyalgia (diagnosed 10 or 11 years ago) (date unspecified). Current conditions included atrial fibrillation (diagnosed around 20 years ago (date unspecified), plantar fasciitis (it used to happen sporadically), Achilles tendonitis (it used to happen sporadically) and slightly raised blood pressure (diagnosed about 1 year ago (date unspecified)). Concomitant medication was not reported. The patient was vaccinated with Seasonal Influenza Virus Vaccine Inn (manufacturer unknown, batch number: not reported) in right arm (RA) on Oct 2015, intramuscularly. It was reported that, illness at the time of vaccination was none. It was reported that, right away following vaccination, the patient experienced redness, swelling and soreness really bad. It was also reported that the adverse event following prior vaccination were most likely in the afternoon after 13:00. The patient did not require emergency room or physician visit and corrective treatment was not reported. The outcome of the events was reported as complete recovery. The events were reported as non-serious by the consumer. The causality of the events was not reported.
Age: 71.0
Sex: F
Vaccine: FLUX, FLUX
Symptoms: Erythema, Pain, Swelling
Clinical narrative: Case number PHHY2016US088931, is an initial spontaneous report received from a consumer via phone via a pharmaceutical company (Pfizer) (Pfizer reference number: 2016164800) through the Vaccine Adverse Event Reporting System (VAERS reference number: 632868) web site on 20 Jun 2016. This report refers to a 71 year old female patient. Historical condition included fibromyalgia (diagnosed 10 or 11 years ago) (date unspecified). Current conditions included atrial fibrillation (diagnosed around 20 years ago (date unspecified), plantar fasciitis (it used to happen sporadically), Achilles tendonitis (it used to happen sporadically) and slightly raised blood pressure (diagnosed about 1 year ago (date unspecified)). Concomitant medication was not reported. The patient was vaccinated with Seasonal Influenza Virus Vaccine Inn (manufacturer unknown, batch number: not reported) in right arm (RA) on Oct 2015, intramuscularly. It was reported that, illness at the time of vaccination was none. It was reported that, right away following vaccination, the patient experienced redness, swelling and soreness really bad. It was also reported that the adverse event following prior vaccination were most likely in the afternoon after 13:00. The patient did not require emergency room or physician visit and corrective treatment was not reported. The outcome of the events was reported as complete recovery. The events were reported as non-serious by the consumer. The causality of the events was not reported.
Sex: F
Vaccine: FLUX, FLUX, FLUX, FLUX
Symptoms: Blood immunoglobulin G, Dizziness, Erythema, Eye swelling, Injection site irritation
Clinical narrative: Case number PHHY2016US090638, is an initial spontaneous report received Vaccine Adverse Event Reporting System (VAERS reference number: 633303) website on 20-Jun-2016. This report refers to a 32 years old female patient. Past medical history included as hypothyroidism, actinic keratosis, lumbago, dermatitis, varicose veins and osteoarthritis (OA). Concomitant medications was not reported. Prior vaccination history included administration of first dose of seasonal influenza vaccine (manufacturer and batch number: not reported) intramuscularly on 07 Nov 1999. It was reported that, the patient concurrently received other vaccines from 2000 to 2015 to include MENVEO vaccine, MMR vaccine, TYPHOID vaccine, TD/TDAP vaccine, Yellow Fever vaccine (YF) and ANTHRAX vaccine adsorbed (AVA) without adverse reactions. The patient had a large red bump to her arm about size of an orange that extended up to her shoulder that lasted about 03 to 05 days. The patient recalled experiencing the same events in 2000 (no vaccine documented) with addition of hives extending to her face/neck and upper chest region (above bra line), had sniffles, her throat itched, and her right eye was swollen. It was stated that, the patient did not receive another flu vaccine for the next several years. The patient vaccinated with seasonal influenza vaccine (manufacturer and batch number: not reported) on 17Mar 2004. On an unknown date, the patient experienced progressive site irritation (small erythematous area at site that would progress each year). The patient visited to the emergency room. The outcome of the events was reported as complete recovery on an unknown date. The seriousness of the events was reported as non serious. The causality of the events was not reported.
Sex: F
Vaccine: FLUX, FLUX, FLUX, FLUX
Symptoms: Local swelling, Palpitations, Respiratory tract congestion, Rhinorrhoea, Tachycardia
Clinical narrative: Case number PHHY2016US090638, is an initial spontaneous report received Vaccine Adverse Event Reporting System (VAERS reference number: 633303) website on 20-Jun-2016. This report refers to a 32 years old female patient. Past medical history included as hypothyroidism, actinic keratosis, lumbago, dermatitis, varicose veins and osteoarthritis (OA). Concomitant medications was not reported. Prior vaccination history included administration of first dose of seasonal influenza vaccine (manufacturer and batch number: not reported) intramuscularly on 07 Nov 1999. It was reported that, the patient concurrently received other vaccines from 2000 to 2015 to include MENVEO vaccine, MMR vaccine, TYPHOID vaccine, TD/TDAP vaccine, Yellow Fever vaccine (YF) and ANTHRAX vaccine adsorbed (AVA) without adverse reactions. The patient had a large red bump to her arm about size of an orange that extended up to her shoulder that lasted about 03 to 05 days. The patient recalled experiencing the same events in 2000 (no vaccine documented) with addition of hives extending to her face/neck and upper chest region (above bra line), had sniffles, her throat itched, and her right eye was swollen. It was stated that, the patient did not receive another flu vaccine for the next several years. The patient vaccinated with seasonal influenza vaccine (manufacturer and batch number: not reported) on 17Mar 2004. On an unknown date, the patient experienced progressive site irritation (small erythematous area at site that would progress each year). The patient visited to the emergency room. The outcome of the events was reported as complete recovery on an unknown date. The seriousness of the events was reported as non serious. The causality of the events was not reported.
Sex: F
Vaccine: FLUX, FLUX, FLUX, FLUX
Symptoms: Throat irritation, Tremor, Urticaria, Wheezing
Clinical narrative: Case number PHHY2016US090638, is an initial spontaneous report received Vaccine Adverse Event Reporting System (VAERS reference number: 633303) website on 20-Jun-2016. This report refers to a 32 years old female patient. Past medical history included as hypothyroidism, actinic keratosis, lumbago, dermatitis, varicose veins and osteoarthritis (OA). Concomitant medications was not reported. Prior vaccination history included administration of first dose of seasonal influenza vaccine (manufacturer and batch number: not reported) intramuscularly on 07 Nov 1999. It was reported that, the patient concurrently received other vaccines from 2000 to 2015 to include MENVEO vaccine, MMR vaccine, TYPHOID vaccine, TD/TDAP vaccine, Yellow Fever vaccine (YF) and ANTHRAX vaccine adsorbed (AVA) without adverse reactions. The patient had a large red bump to her arm about size of an orange that extended up to her shoulder that lasted about 03 to 05 days. The patient recalled experiencing the same events in 2000 (no vaccine documented) with addition of hives extending to her face/neck and upper chest region (above bra line), had sniffles, her throat itched, and her right eye was swollen. It was stated that, the patient did not receive another flu vaccine for the next several years. The patient vaccinated with seasonal influenza vaccine (manufacturer and batch number: not reported) on 17Mar 2004. On an unknown date, the patient experienced progressive site irritation (small erythematous area at site that would progress each year). The patient visited to the emergency room. The outcome of the events was reported as complete recovery on an unknown date. The seriousness of the events was reported as non serious. The causality of the events was not reported.
Sex: F
Vaccine: FLUX, FLUX, FLUX, FLUX
Symptoms: Erythema, Eye swelling, Peripheral swelling, Rhinorrhoea, Throat irritation
Clinical narrative: Case number PHHY2016US090638, is an initial spontaneous report received Vaccine Adverse Event Reporting System (VAERS reference number: 633303) website on 20-Jun-2016. This report refers to a 32 years old female patient. Past medical history included as hypothyroidism, actinic keratosis, lumbago, dermatitis, varicose veins and osteoarthritis (OA). Concomitant medications was not reported. Prior vaccination history included administration of first dose of seasonal influenza vaccine (manufacturer and batch number: not reported) intramuscularly on 07 Nov 1999. It was reported that, the patient concurrently received other vaccines from 2000 to 2015 to include MENVEO vaccine, MMR vaccine, TYPHOID vaccine, TD/TDAP vaccine, Yellow Fever vaccine (YF) and ANTHRAX vaccine adsorbed (AVA) without adverse reactions. The patient had a large red bump to her arm about size of an orange that extended up to her shoulder that lasted about 03 to 05 days. The patient recalled experiencing the same events in 2000 (no vaccine documented) with addition of hives extending to her face/neck and upper chest region (above bra line), had sniffles, her throat itched, and her right eye was swollen. It was stated that, the patient did not receive another flu vaccine for the next several years. The patient vaccinated with seasonal influenza vaccine (manufacturer and batch number: not reported) on 17Mar 2004. On an unknown date, the patient experienced progressive site irritation (small erythematous area at site that would progress each year). The patient visited to the emergency room. The outcome of the events was reported as complete recovery on an unknown date. The seriousness of the events was reported as non serious. The causality of the events was not reported.
Sex: F
Vaccine: FLUX, FLUX, FLUX, FLUX
Symptoms: Urticaria
Clinical narrative: Case number PHHY2016US090638, is an initial spontaneous report received Vaccine Adverse Event Reporting System (VAERS reference number: 633303) website on 20-Jun-2016. This report refers to a 32 years old female patient. Past medical history included as hypothyroidism, actinic keratosis, lumbago, dermatitis, varicose veins and osteoarthritis (OA). Concomitant medications was not reported. Prior vaccination history included administration of first dose of seasonal influenza vaccine (manufacturer and batch number: not reported) intramuscularly on 07 Nov 1999. It was reported that, the patient concurrently received other vaccines from 2000 to 2015 to include MENVEO vaccine, MMR vaccine, TYPHOID vaccine, TD/TDAP vaccine, Yellow Fever vaccine (YF) and ANTHRAX vaccine adsorbed (AVA) without adverse reactions. The patient had a large red bump to her arm about size of an orange that extended up to her shoulder that lasted about 03 to 05 days. The patient recalled experiencing the same events in 2000 (no vaccine documented) with addition of hives extending to her face/neck and upper chest region (above bra line), had sniffles, her throat itched, and her right eye was swollen. It was stated that, the patient did not receive another flu vaccine for the next several years. The patient vaccinated with seasonal influenza vaccine (manufacturer and batch number: not reported) on 17Mar 2004. On an unknown date, the patient experienced progressive site irritation (small erythematous area at site that would progress each year). The patient visited to the emergency room. The outcome of the events was reported as complete recovery on an unknown date. The seriousness of the events was reported as non serious. The causality of the events was not reported.
Sex: F
Vaccine: FLUX, FLUX, FLUX, FLUX
Symptoms: Injection site erythema, Injection site irritation
Clinical narrative: Case number PHHY2016US090638, is an initial spontaneous report received Vaccine Adverse Event Reporting System (VAERS reference number: 633303) website on 20-Jun-2016. This report refers to a 32 years old female patient. Past medical history included as hypothyroidism, actinic keratosis, lumbago, dermatitis, varicose veins and osteoarthritis (OA). Concomitant medications was not reported. Prior vaccination history included administration of first dose of seasonal influenza vaccine (manufacturer and batch number: not reported) intramuscularly on 07 Nov 1999. It was reported that, the patient concurrently received other vaccines from 2000 to 2015 to include MENVEO vaccine, MMR vaccine, TYPHOID vaccine, TD/TDAP vaccine, Yellow Fever vaccine (YF) and ANTHRAX vaccine adsorbed (AVA) without adverse reactions. The patient had a large red bump to her arm about size of an orange that extended up to her shoulder that lasted about 03 to 05 days. The patient recalled experiencing the same events in 2000 (no vaccine documented) with addition of hives extending to her face/neck and upper chest region (above bra line), had sniffles, her throat itched, and her right eye was swollen. It was stated that, the patient did not receive another flu vaccine for the next several years. The patient vaccinated with seasonal influenza vaccine (manufacturer and batch number: not reported) on 17Mar 2004. On an unknown date, the patient experienced progressive site irritation (small erythematous area at site that would progress each year). The patient visited to the emergency room. The outcome of the events was reported as complete recovery on an unknown date. The seriousness of the events was reported as non serious. The causality of the events was not reported.
Sex: F
Vaccine: FLUX, FLUX, FLUX, FLUX
Symptoms: Erythema, Hepatitis B antibody positive, Injection site erythema, Injection site irritation, Measles antibody positive
Clinical narrative: Case number PHHY2016US090638, is an initial spontaneous report received Vaccine Adverse Event Reporting System (VAERS reference number: 633303) website on 20-Jun-2016. This report refers to a 32 years old female patient. Past medical history included as hypothyroidism, actinic keratosis, lumbago, dermatitis, varicose veins and osteoarthritis (OA). Concomitant medications was not reported. Prior vaccination history included administration of first dose of seasonal influenza vaccine (manufacturer and batch number: not reported) intramuscularly on 07 Nov 1999. It was reported that, the patient concurrently received other vaccines from 2000 to 2015 to include MENVEO vaccine, MMR vaccine, TYPHOID vaccine, TD/TDAP vaccine, Yellow Fever vaccine (YF) and ANTHRAX vaccine adsorbed (AVA) without adverse reactions. The patient had a large red bump to her arm about size of an orange that extended up to her shoulder that lasted about 03 to 05 days. The patient recalled experiencing the same events in 2000 (no vaccine documented) with addition of hives extending to her face/neck and upper chest region (above bra line), had sniffles, her throat itched, and her right eye was swollen. It was stated that, the patient did not receive another flu vaccine for the next several years. The patient vaccinated with seasonal influenza vaccine (manufacturer and batch number: not reported) on 17Mar 2004. On an unknown date, the patient experienced progressive site irritation (small erythematous area at site that would progress each year). The patient visited to the emergency room. The outcome of the events was reported as complete recovery on an unknown date. The seriousness of the events was reported as non serious. The causality of the events was not reported.
Sex: F
Vaccine: FLUX, FLUX, FLUX, FLUX
Symptoms: Morbillivirus test positive, Mumps antibody test positive, Peripheral swelling, Rubella antibody positive, Rubivirus test positive
Clinical narrative: Case number PHHY2016US090638, is an initial spontaneous report received Vaccine Adverse Event Reporting System (VAERS reference number: 633303) website on 20-Jun-2016. This report refers to a 32 years old female patient. Past medical history included as hypothyroidism, actinic keratosis, lumbago, dermatitis, varicose veins and osteoarthritis (OA). Concomitant medications was not reported. Prior vaccination history included administration of first dose of seasonal influenza vaccine (manufacturer and batch number: not reported) intramuscularly on 07 Nov 1999. It was reported that, the patient concurrently received other vaccines from 2000 to 2015 to include MENVEO vaccine, MMR vaccine, TYPHOID vaccine, TD/TDAP vaccine, Yellow Fever vaccine (YF) and ANTHRAX vaccine adsorbed (AVA) without adverse reactions. The patient had a large red bump to her arm about size of an orange that extended up to her shoulder that lasted about 03 to 05 days. The patient recalled experiencing the same events in 2000 (no vaccine documented) with addition of hives extending to her face/neck and upper chest region (above bra line), had sniffles, her throat itched, and her right eye was swollen. It was stated that, the patient did not receive another flu vaccine for the next several years. The patient vaccinated with seasonal influenza vaccine (manufacturer and batch number: not reported) on 17Mar 2004. On an unknown date, the patient experienced progressive site irritation (small erythematous area at site that would progress each year). The patient visited to the emergency room. The outcome of the events was reported as complete recovery on an unknown date. The seriousness of the events was reported as non serious. The causality of the events was not reported.
Sex: F
Vaccine: FLUX, FLUX, FLUX, FLUX
Symptoms: Rubulavirus test positive
Clinical narrative: Case number PHHY2016US090638, is an initial spontaneous report received Vaccine Adverse Event Reporting System (VAERS reference number: 633303) website on 20-Jun-2016. This report refers to a 32 years old female patient. Past medical history included as hypothyroidism, actinic keratosis, lumbago, dermatitis, varicose veins and osteoarthritis (OA). Concomitant medications was not reported. Prior vaccination history included administration of first dose of seasonal influenza vaccine (manufacturer and batch number: not reported) intramuscularly on 07 Nov 1999. It was reported that, the patient concurrently received other vaccines from 2000 to 2015 to include MENVEO vaccine, MMR vaccine, TYPHOID vaccine, TD/TDAP vaccine, Yellow Fever vaccine (YF) and ANTHRAX vaccine adsorbed (AVA) without adverse reactions. The patient had a large red bump to her arm about size of an orange that extended up to her shoulder that lasted about 03 to 05 days. The patient recalled experiencing the same events in 2000 (no vaccine documented) with addition of hives extending to her face/neck and upper chest region (above bra line), had sniffles, her throat itched, and her right eye was swollen. It was stated that, the patient did not receive another flu vaccine for the next several years. The patient vaccinated with seasonal influenza vaccine (manufacturer and batch number: not reported) on 17Mar 2004. On an unknown date, the patient experienced progressive site irritation (small erythematous area at site that would progress each year). The patient visited to the emergency room. The outcome of the events was reported as complete recovery on an unknown date. The seriousness of the events was reported as non serious. The causality of the events was not reported.
Sex: F
Vaccine: FLUX, FLUX, FLUX, FLUX
Symptoms: Blood immunoglobulin G, Dizziness, Erythema, Eye swelling, Injection site irritation
Clinical narrative: Case number PHHY2016US090708, is an initial spontaneous report received Vaccine Adverse Event Reporting System (VAERS reference number: 633303) website on 20 Jun 2016. This report refers to a 32 years old female patient. Past medical history included as hypothyroidism, actinic keratosis, lumbago, dermatitis, varicose veins and osteoarthritis (OA). Concomitant medications was not reported. Prior vaccination history included administration of first dose of seasonal influenza vaccine (manufacturer and batch number not reported) intramuscularly on 07 Nov 1999. It was reported that, the patient concurrently received other vaccines from 2000 to 2015 to include MENVEO vaccine, MMR vaccine, Typhoid vaccine, Td/Tdap vaccine, Yellow fever vaccine and Anthrax vaccine absorbed without adverse reactions. The patient had a large red bump to her arm about size of an orange that extended up to her shoulder that lasted about 03 to 05 days. The patient experienced same thing occurring in 2000 (no vaccine documented) with addition of hives extending to her face/neck and upper chest region (above bra line), had sniffles, her throat itched, and her right eye was swollen. It was stated that, the patient did not receive another flu vaccine for the next years. The patient vaccinated with seasonal influenza vaccine (manufacturer and batch number: not reported) on 17 Mar 2004 and Influenza vaccine on an unknown date in Oct 2006 (Med immune 500433P) and experienced progressive site irritation (small erythematous area at site). The patient also vaccinated with Flu mist on 22 Nov 2008 and 28 Aug 2009 with no adverse reaction. The patient vaccinated with H1N1 influenza vaccine (batch number: not reported) on 25 Nov 2009 and experienced progressive site irritation (small erythematous area at site that would progress each year). The patient vaccinated with seasonal influenza vaccine (manufacturer and batch number: not reported) on 25 Sep 2010. On an unknown date, the patient experienced progressive site irritation (small erythematous area at site that would progress each year). It was stated that, allergist note on 18 Apr 2012, listed possible hepatitis B non-responder with negative varicella IgG, and positive MMR titers from 2009. The patient visited to the emergency room. The outcome of the events was reported as complete recovery on an unknown date. The seriousness of the events was reported as non serious. The causality of the events was not reported. Following internal review done on 05 Jul 2016 for the data received on 20 Jun 2016: Following changes were done. Events Hepatitis, Measles virus test positive, Mumps virus test positive and Rubella virus test positive were deleted from the event tab as these events were not experienced by the patient.
Sex: F
Vaccine: FLUX, FLUX, FLUX, FLUX
Symptoms: Local swelling, Palpitations, Respiratory tract congestion, Rhinorrhoea, Tachycardia
Clinical narrative: Case number PHHY2016US090708, is an initial spontaneous report received Vaccine Adverse Event Reporting System (VAERS reference number: 633303) website on 20 Jun 2016. This report refers to a 32 years old female patient. Past medical history included as hypothyroidism, actinic keratosis, lumbago, dermatitis, varicose veins and osteoarthritis (OA). Concomitant medications was not reported. Prior vaccination history included administration of first dose of seasonal influenza vaccine (manufacturer and batch number not reported) intramuscularly on 07 Nov 1999. It was reported that, the patient concurrently received other vaccines from 2000 to 2015 to include MENVEO vaccine, MMR vaccine, Typhoid vaccine, Td/Tdap vaccine, Yellow fever vaccine and Anthrax vaccine absorbed without adverse reactions. The patient had a large red bump to her arm about size of an orange that extended up to her shoulder that lasted about 03 to 05 days. The patient experienced same thing occurring in 2000 (no vaccine documented) with addition of hives extending to her face/neck and upper chest region (above bra line), had sniffles, her throat itched, and her right eye was swollen. It was stated that, the patient did not receive another flu vaccine for the next years. The patient vaccinated with seasonal influenza vaccine (manufacturer and batch number: not reported) on 17 Mar 2004 and Influenza vaccine on an unknown date in Oct 2006 (Med immune 500433P) and experienced progressive site irritation (small erythematous area at site). The patient also vaccinated with Flu mist on 22 Nov 2008 and 28 Aug 2009 with no adverse reaction. The patient vaccinated with H1N1 influenza vaccine (batch number: not reported) on 25 Nov 2009 and experienced progressive site irritation (small erythematous area at site that would progress each year). The patient vaccinated with seasonal influenza vaccine (manufacturer and batch number: not reported) on 25 Sep 2010. On an unknown date, the patient experienced progressive site irritation (small erythematous area at site that would progress each year). It was stated that, allergist note on 18 Apr 2012, listed possible hepatitis B non-responder with negative varicella IgG, and positive MMR titers from 2009. The patient visited to the emergency room. The outcome of the events was reported as complete recovery on an unknown date. The seriousness of the events was reported as non serious. The causality of the events was not reported. Following internal review done on 05 Jul 2016 for the data received on 20 Jun 2016: Following changes were done. Events Hepatitis, Measles virus test positive, Mumps virus test positive and Rubella virus test positive were deleted from the event tab as these events were not experienced by the patient.
Sex: F
Vaccine: FLUX, FLUX, FLUX, FLUX
Symptoms: Throat irritation, Tremor, Urticaria, Wheezing
Clinical narrative: Case number PHHY2016US090708, is an initial spontaneous report received Vaccine Adverse Event Reporting System (VAERS reference number: 633303) website on 20 Jun 2016. This report refers to a 32 years old female patient. Past medical history included as hypothyroidism, actinic keratosis, lumbago, dermatitis, varicose veins and osteoarthritis (OA). Concomitant medications was not reported. Prior vaccination history included administration of first dose of seasonal influenza vaccine (manufacturer and batch number not reported) intramuscularly on 07 Nov 1999. It was reported that, the patient concurrently received other vaccines from 2000 to 2015 to include MENVEO vaccine, MMR vaccine, Typhoid vaccine, Td/Tdap vaccine, Yellow fever vaccine and Anthrax vaccine absorbed without adverse reactions. The patient had a large red bump to her arm about size of an orange that extended up to her shoulder that lasted about 03 to 05 days. The patient experienced same thing occurring in 2000 (no vaccine documented) with addition of hives extending to her face/neck and upper chest region (above bra line), had sniffles, her throat itched, and her right eye was swollen. It was stated that, the patient did not receive another flu vaccine for the next years. The patient vaccinated with seasonal influenza vaccine (manufacturer and batch number: not reported) on 17 Mar 2004 and Influenza vaccine on an unknown date in Oct 2006 (Med immune 500433P) and experienced progressive site irritation (small erythematous area at site). The patient also vaccinated with Flu mist on 22 Nov 2008 and 28 Aug 2009 with no adverse reaction. The patient vaccinated with H1N1 influenza vaccine (batch number: not reported) on 25 Nov 2009 and experienced progressive site irritation (small erythematous area at site that would progress each year). The patient vaccinated with seasonal influenza vaccine (manufacturer and batch number: not reported) on 25 Sep 2010. On an unknown date, the patient experienced progressive site irritation (small erythematous area at site that would progress each year). It was stated that, allergist note on 18 Apr 2012, listed possible hepatitis B non-responder with negative varicella IgG, and positive MMR titers from 2009. The patient visited to the emergency room. The outcome of the events was reported as complete recovery on an unknown date. The seriousness of the events was reported as non serious. The causality of the events was not reported. Following internal review done on 05 Jul 2016 for the data received on 20 Jun 2016: Following changes were done. Events Hepatitis, Measles virus test positive, Mumps virus test positive and Rubella virus test positive were deleted from the event tab as these events were not experienced by the patient.
Sex: F
Vaccine: FLUX, FLUX, FLUX, FLUX
Symptoms: Erythema, Eye swelling, Peripheral swelling, Rhinorrhoea, Throat irritation
Clinical narrative: Case number PHHY2016US090708, is an initial spontaneous report received Vaccine Adverse Event Reporting System (VAERS reference number: 633303) website on 20 Jun 2016. This report refers to a 32 years old female patient. Past medical history included as hypothyroidism, actinic keratosis, lumbago, dermatitis, varicose veins and osteoarthritis (OA). Concomitant medications was not reported. Prior vaccination history included administration of first dose of seasonal influenza vaccine (manufacturer and batch number not reported) intramuscularly on 07 Nov 1999. It was reported that, the patient concurrently received other vaccines from 2000 to 2015 to include MENVEO vaccine, MMR vaccine, Typhoid vaccine, Td/Tdap vaccine, Yellow fever vaccine and Anthrax vaccine absorbed without adverse reactions. The patient had a large red bump to her arm about size of an orange that extended up to her shoulder that lasted about 03 to 05 days. The patient experienced same thing occurring in 2000 (no vaccine documented) with addition of hives extending to her face/neck and upper chest region (above bra line), had sniffles, her throat itched, and her right eye was swollen. It was stated that, the patient did not receive another flu vaccine for the next years. The patient vaccinated with seasonal influenza vaccine (manufacturer and batch number: not reported) on 17 Mar 2004 and Influenza vaccine on an unknown date in Oct 2006 (Med immune 500433P) and experienced progressive site irritation (small erythematous area at site). The patient also vaccinated with Flu mist on 22 Nov 2008 and 28 Aug 2009 with no adverse reaction. The patient vaccinated with H1N1 influenza vaccine (batch number: not reported) on 25 Nov 2009 and experienced progressive site irritation (small erythematous area at site that would progress each year). The patient vaccinated with seasonal influenza vaccine (manufacturer and batch number: not reported) on 25 Sep 2010. On an unknown date, the patient experienced progressive site irritation (small erythematous area at site that would progress each year). It was stated that, allergist note on 18 Apr 2012, listed possible hepatitis B non-responder with negative varicella IgG, and positive MMR titers from 2009. The patient visited to the emergency room. The outcome of the events was reported as complete recovery on an unknown date. The seriousness of the events was reported as non serious. The causality of the events was not reported. Following internal review done on 05 Jul 2016 for the data received on 20 Jun 2016: Following changes were done. Events Hepatitis, Measles virus test positive, Mumps virus test positive and Rubella virus test positive were deleted from the event tab as these events were not experienced by the patient.